C12N 2501/18
Liver cell growth factor
Official title: Liver cell growth factor (LCGF, Gly-His-Lys)
C12N2501/18 (Liver cell growth factor) appears on 14 US grants and 14 published applications in this corpus.
Search patents in C12N- Granted patents
- 14
- Published applications
- 14
- Assignees
- 9
- Inventors
- 23
- Latest grant
- 3 Jul 2012
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1986 | 2 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 0 | 0 |
| 1998 | 4 | 0 |
| 1999 | 0 | 0 |
| 2000 | 0 | 0 |
| 2001 | 1 | 0 |
| 2002 | 1 | 3 |
| 2003 | 0 | 0 |
| 2004 | 0 | 1 |
| 2005 | 0 | 3 |
| 2006 | 0 | 1 |
| 2007 | 1 | 0 |
| 2008 | 1 | 1 |
| 2009 | 0 | 2 |
| 2010 | 1 | 0 |
| 2011 | 1 | 2 |
| 2012 | 2 | 0 |
| 2013 | 0 | 1 |
By publication year. Applications have been published since 2001.
Recent patents
- Method useful for HCV RNA898 infection3 Jul 2012US 8,211,696 B2Vertex Pharmaceuticals Incorporated
- Methods of controlling proliferation and differentiation of stem and progenitor cells19 Jun 2012US 8,202,724 B2Gamida Cell Ltd.
- Compositions and methods useful for HCV infection1 Feb 2011US 7,879,606 B2Vertex Pharmaceuticals Incorporated
- Methods of controlling proliferation and differentiation of stem and progenitor cells21 Dec 2010US 7,855,075 B2Gamida Cell Ltd.
- Methods of controlling proliferation and differentiation of stem and progenitor cells30 Sep 2008US 7,429,489 B2Gamida Cell Ltd.
- Compositions and methods useful for hcv infection21 Mar 2013US 2013/0071834 A1Vertex Pharmaceuticals Incorporated
- Compositions and methods useful for hcv infection22 Sep 2011US 2011/0229874 A1Vertex Pharmaceuticals Incorporated
- Methods Of Controlling Proliferation And Differentiation Of Stem And Progenitor Cells24 Feb 2011US 2011/0045589 A1Gamida Cell Ltd.
- Embryonic stem cells capable of differentiating into desired cell lines8 Oct 2009US 2009/0253201 A1Diacrin, Inc.
- Methods of controlling proliferation and differentiation of stem and progenitor cells1 Jan 2009US 2009/0004158 A1Gamida Cell Ltd.
Most cited
By later US patents
- Three-dimensional fibrous scaffold containing attached cells for producing vascularized tissue in vivo261US 5,770,417 AMassachusetts Institute of Technology Children's Medical Center Corporation · 1998
- Three-dimensional fibrous scaffold containing attached cells for producing vascularized tissue in vivo210US 5,759,830 AChildren's Medical Center Corporation · 1998
- Preparation of three-dimensional fibrous scaffold for attaching cells to produce vascularized tissue in vivo159US 5,770,193 AMassachusetts Institute of Technology Children's Medical Center Corporation · 1998
- Implantation of cell-matrix structure adjacent mesentery, omentum or peritoneum tissue100US 5,804,178 AChildren's Medical Center Corporation · 1998
- Embryonic stem cells capable of differentiating into desired cell lines42US 6,432,711 B1Diacrin, Inc. · 2002